NTLA
Intellia Therapeutics, Inc. · Wikipedia · Yahoo Finance chart ↗
Price
- Last close
- $12.47Last update Oct 30, 2026
- 12-month high
- $18.48
- 12-month low
- $7.95
Reported holders
Politicians whose newest complete holdings report lists this stock, or who reported buying it after that report (or at any time, if they have no usable report). A later full sale that could have closed the position removes them.
| Name | Purchased | Price that day | ROI |
|---|---|---|---|
| No reported holders yet. | |||
All trades
| Ticker | Politician Name | Transaction Type | Trade Date | Found Date |
|---|---|---|---|---|
| NTLA — Intellia Therapeutics, Inc. - Common Stock, Thomas R. Carper, sale, Aug 25, 2023 | Thomas R. Carper | Sale | Aug 25, 2023 | Oct 30, 2026 |
| NTLA — Intellia Therapeutics, Inc. - Common Stock, Thomas R. Carper, purchase, May 22, 2023 | Thomas R. Carper | Purchase | May 22, 2023 | Oct 30, 2026 |
| NTLA — Intellia Therapeutics, Inc. (NTLA) [ST], Donald Sternoff Beyer Jr, sale, Feb 28, 2022 | Donald Sternoff Beyer Jr Rank #103 | Sale | Feb 28, 2022 | Sep 12, 2026 |